| Robust Protective Effects of a Novel Multimodal Neuroprotectant Oxopropanoyloxy Benzoic Acid (a Salicylic Acid/Pyruvate Ester) in the Postischemic Brain. | |
| | |
MedLine Citation:
|
PMID: 21036874 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Cerebral ischemia leads to brain injury via a complex series of pathophysiological events. Therefore, multidrug treatments or multitargeting drug treatments are attractive options in efficiently limiting brain damage. Here, we report a novel multifunctional compound oxopropanoyloxy benzoic acid (OBA-09), a simple ester of pyruvate and salicylic acid. This protective effect was manifested by recoveries from neurological and behavioral deficits. OBA-09 exhibited antioxidative effects in the postischemic brain, which was evidenced by remarkable reduction of lipid peroxidation and 4-hydroxy-2-nonenal staining in OBA-09-administered animals. Reactive oxygen species generation was markedly suppressed in primary cortical cultures under oxygen-glucose deprivation. More interestingly, OBA-09 was capable of scavenging hydroxyl radical in cell-free assays. High-performance liquid chromatography results demonstrated that OBA-09 was hydrolyzed to salicylic acid and pyruvate with t(1/2) = 43 min in serum and 4.2 h in brain parenchyma, indicating that antioxidative function of OBA-09 is executed by itself and also by salicylic acid after the hydrolysis. In addition to antioxidative function, OBA-09 exerts anti-excitotoxic and anti-Zn(2+)-toxic functions, which might be attributed to attenuation of ATP and nicotinamide adenine dinucleotide depletion and to the suppression of nuclear factor-κB activity induction. Together these results indicate that OBA-09 has a potent therapeutic potential as a multimodal neuroprotectant in the postischemic brain and these effects were conferred by OBA-09 itself and subsequently its hydrolyzed products. |
| | |
Authors:
|
Seung-Woo Kim; Hyun Ji Kim; Joo-Hyun Shin; Il-Doo Kim; Jung-Eun Lee; Pyung-Lim Han; Sung-Hwa Yoon; Ja-Kyeong Lee |
Related Documents
:
|
16039064 - Amino acids and transaminases activity in ventricular csf and in brain of normal and al... 8941854 - Neurochemical mechanisms in brain injury and treatment: a review. 10557334 - Serine racemase: a glial enzyme synthesizing d-serine to regulate glutamate-n-methyl-d-... 974194 - Precursor and end product effects upon indoleamine maturation in mouse brain. 19632114 - Metallo-beta-lactamase inhibitory activity of phthalic acid derivatives. 15389854 - Analysis of nucleic acids by fticr ms. |
Publication Detail:
|
Type: Journal Article Date: 2010-10-29 |
Journal Detail:
|
Title: Molecular pharmacology Volume: 79 ISSN: 1521-0111 ISO Abbreviation: Mol. Pharmacol. Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-01-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0035623 Medline TA: Mol Pharmacol Country: United States |
Other Details:
|
Languages: eng Pagination: 220-8 Citation Subset: IM |
Affiliation:
|
Department of Anatomy, Inha University School of Medicine. 7-241 Shinheung-dong, Jung-Gu, Inchon, 400-712, Republic of Korea. jklee@inha.ac.kr. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: AtPID: the overall hierarchical functional protein interaction network interface and analytic platfo...
Next Document: Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid...